Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 306M | 398M | 326M | 333M |
Cost of revenue | 176M | 217M | 185M | 187M |
Gross profit | 130M | 181M | 141M | 146M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 104M | 106M | 98M | 102M |
Operating income | 20M | 68M | 39M | 40M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 7M | 2M | 10M | 6M |
Other income expense | — | — | — | — |
Pretax income | 13M | 66M | 30M | 33M |
Tax provision | 3M | 15M | 7M | 8M |
Net income | 10M | 51M | 22M | 25M |
Basic EPS | 0.0 | 0.2 | 0.1 | 0.1 |
Diluted EPS | 0.0 | 0.2 | 0.1 | 0.1 |
Basic average shares | 333.3M | 294.1M | 285.7M | 287.5M |
Diluted average shares | 333.3M | 294.1M | 285.7M | 287.5M |
EBITDA | 47M | 98M | 63M | 63M |
Net income from continuing op. | 13M | 66M | 30M | 33M |
Minority interests | 0 | -1M | -2M | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |